 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
8-12-2022
Insider Buy |
Jackson P. Tai
Director |
$304.19
CAGR »
|
$199,548.64
656 shares |
3-1-2022
Insider Buy |
Marschall S. Runge
Director |
$246.78
CAGR »
|
$49,849.56
202 shares |
4-30-2021
Insider Buy |
Jackson P. Tai
Director |
$182.84
CAGR »
|
$249,759.34
1,366 shares |
10-25-2019
Insider Buy |
Daniel Skovronsky
SVP, CSO, and Pres. LRL |
$108.61
CAGR »
|
$543,050.00
5,000 shares |
10-25-2019
Insider Buy |
Joshua L. Smiley
SVP and CFO |
$107.59
CAGR »
|
$99,951.11
929 shares |
10-25-2019
Insider Buy |
Anne E. White
SVP & Pres-Lilly Oncology |
$108.84
CAGR »
|
$108,840.00
1,000 shares |
10-24-2019
Insider Buy |
Jackson P. Tai
Director |
$107.49
CAGR »
|
$200,038.89
1,861 shares |
10-25-2019
Insider Buy |
David A. Ricks
President & CEO |
$108.38
CAGR »
|
$500,173.70
4,615 shares |
7-15-2019
Insider Buy |
Joshua L. Smiley
SVP and CFO |
$108.47
CAGR »
|
$20,066.95
185 shares |
6-5-2019
Insider Buy |
Joshua L. Smiley
SVP and CFO |
$118.03
CAGR »
|
$50,280.78
426 shares |
7-26-2018
Insider Buy |
Jackson P. Tai
Director |
$95.22
CAGR »
|
$149,304.96
1,568 shares |
6-14-2018
Insider Buy |
Daniel Skovronsky
SVP, CSO, and Pres. LRL |
$86.22
CAGR »
|
$862,200.00
10,000 shares |
12-16-2016
Insider Buy |
Jackson P. Tai
Director |
$72.64
CAGR »
|
$99,880.00
1,375 shares |
12-16-2016
Insider Buy |
R. David Hoover
Director |
$71.85
CAGR »
|
$35,925.00
500 shares |
8-15-2016
Insider Buy |
Jackson P. Tai
Director |
$80.43
CAGR »
|
$464,348.32
5,773 shares |
5-12-2016
Insider Buy |
Jackson P. Tai
Director |
$75.75
CAGR »
|
$81,810.00
1,080 shares |
2-1-2016
Insider Buy |
Jackson P. Tai
Director |
$78.62
CAGR »
|
$249,225.40
3,170 shares |
5-12-2014
Insider Buy |
Jackson P. Tai
Director |
$59.19
CAGR »
|
$1,015,437.83
17,157 shares |
Also See: Institutional Holders of LLY
Also See: SEC filings
Below we present the annualized performance delivered by LLY stock since 8-12-2022 (the date of the most recent
insider purchase). The performance of the investment from the time LLY insider buying occurred is the ultimate
test of whether insiders were right about LLY being a good buy.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
08/15/2022 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$313.94 |
|
| End price/share: |
$732.20 |
|
| Starting shares: |
31.85 |
|
| Ending shares: |
32.31 |
|
| Dividends reinvested/share: |
$6.80 |
|
| Total return: |
136.58% |
|
| Average Annual Total Return: |
66.29% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$23,657.00 |
|
| Years: |
1.69 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
08/15/2022 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$313.94 |
|
| End price/share: |
$732.20 |
|
| Dividends collected/share: |
$6.80 |
|
| Total return: |
135.40% |
|
| Average Annual Total Return: |
65.80% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$23,539.09 |
|
| Years: |
1.69 |
|
LLY Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent LLY insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding LLY
|
|
Free LLY Email Alerts:
